text
"['\n3. 원재료 및 생산설비\n가. 주요 원재료 가격변동추이\n(단위 : 원)\n품 \xa0목\n제11기\n제10기\n제9기\n원료\n주블리아액\n수 \xa0입\n\xa0 \xa0 \xa021,157\xa0\n\xa0 19,208\xa0\n\xa0 22,752\xa0\nLimaprost\n수 \xa0입\n\xa0 \xa017,251\xa0\n\xa0 18,207\xa0\n\xa0 19,578\xa0\nDapagliflozin formate\n국 \xa0내\n68,313\xa0\n-\xa0\n-\xa0\nD-CYCLOSERINE\n국 \xa0내\n700\xa0\n511\xa0\n512\xa0\n(1) 산출기준- 단순 평균가격에 의한 산출(2) 주요 가격변동 원인- 인건비의 상승 및 하락 - 원재료비의 상승 및 하락- 환율의 상승 및 하락(3) 공급의 안전성 등- 당사의 원재료는 경쟁적인 시장이 조성되어 있고, 장기계약을 통하여 공급받기 때문에 안정적인 원재료 수급이 가능합니다.\n나. 주요 원재료 매입현황\n(단위 : 백만원, %)\n사업부문\n매입유형\n품 \xa0 목\n구체적용도\n매입액\n비율\n주요 매입처\n의약품\n원료\n주블리아액\n주블리아\n\xa012,294\n14.9\nKAKEN Pharm\nLimaprost\n오팔몬\n\xa010,488\n12.7\nOno Pharm\nDapagliflozin formate\n다파프로\n\xa0 \xa08,959\n10.8\n에스티팜\nD-CYCLOSERINE\n크로세린\n\xa0 \xa04,033\n4.9\n에스티팜\n주1) 상기 비율은 재료 + 원료 전체 매입액 대비 비율입니다.다. 생산능력(1) 생산능력\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0(단위: 천개, 천원)\n사업부문\n품 목\n사업소\n제11기\n제10기\n제9기\n수량\n금액\n수량\n금액\n수량\n금액\n의약품등\n모티리톤 500T\n천안캠퍼스\n\xa0380\n\xa0 \xa038,529,416\n\xa0 \xa0 507\n\xa0 \xa038,529,416\n\xa0 \xa0 524\n\xa0 \xa039,834,086\n스티렌 \xa0500T\n〃\n\xa0 \xa0 284\n\xa0 \xa030,844,147\n\xa0 \xa0 379\n\xa0 \xa030,844,147\n\xa0 \xa0477\n\xa0 \xa032,388,403\n플라비톨 300T\n〃\n\xa0 \xa0 \xa0 68\n\xa0 \xa031,315,365\n\xa0 \xa0 \xa0 91\n\xa0 \xa031,315,365\n\xa0 \xa0 \xa074\n\xa0 \xa025,613,036\n가스터 300T\n〃\n\xa0 \xa0 269\n\xa0 \xa019,332,000\n\xa0 \xa0 358\n\xa0 \xa019,332,000\n\xa0 \xa0 320\n\xa0 \xa017,280,000\n리피논 300T\n〃\n\xa0 \xa0 \xa078\n\xa0 \xa019,910,934\n\xa0 \xa0 104\n\xa0 \xa019,910,934\n\xa0 \xa0 109\n\xa0 \xa020,754,197\n오팔몬 84T\n〃\n\xa0 \xa0 826\n\xa0 \xa029,596,493\n\xa01,101\n\xa0 \xa029,596,493\n\xa01,121\n\xa0 \xa030,136,433\n주블리아 4mL\n〃\n\xa0 \xa0 591\n\xa0 \xa030,732,000\n\xa0 \xa0 788\n\xa0 \xa030,732,000\n\xa0 \xa0 537\n\xa0 \xa020,943,000\n크로세린30캡슐\n〃\n\xa0 \xa0 553\n\xa0 \xa0 \xa08,350,891\n\xa0 \xa0 737\n\xa0 \xa0 \xa08,350,891\n\xa0 \xa0 577\n\xa0 \xa0 \xa05,708,603\n그로트로핀주\n대구캠퍼스\n\xa0 \xa0 221\n\xa0 \xa048,707,474\n\xa0 \xa0 295\n\xa0 \xa048,707,474\n\xa0 \xa0 270\n\xa0 \xa044,580,780\n슈가논 30T\n송도캠퍼스\n\xa01,599\n\xa0 \xa035,340,743\n\xa02,131\n\xa0 \xa035,340,743\n\xa01,719\n\xa0 \xa027,531,687\n기 타\n-\n\u3000-\n\xa0246,095,431\n\u3000-\n\xa0246,095,431\n\u3000-\n\xa0206,816,099\n합 계\n\u3000-\n\xa0538,754,894\n\u3000-\n\xa0538,754,894\n\u3000-\n\xa0471,586,324\n(2) 생산능력의 산출근거\n(가) 산출기준\n\xa0- 주요생산설비의 CAPACITY를 기준으로 작성 \xa0·정 \xa0 제 : 타정기 \xa0·캅셀제 : 충전기\n\xa0 ·산 \xa0 제 : 과립기 \xa0·포 \xa0 장 : 포장기 \xa0·주사제 : 충전기- 한 기계에 여러 제품 적용하는 경우 전년도 생산량 기준으로 능력 배분\n(나) 산출방법\n\xa0- 설비능력 × 작업일수\n(다) 평균가동시간\n\xa0- 1일 8시간, 1개월 21일, 1년 12개월 가동 기준\n라. 생산실적\n(단위 : 천개, 천원)\n사업부문\n품 목\n사업소\n제11기\n제10기\n제9기\n수량\n금액\n수량\n금액\n수량\n금액\n의약품등\n모티리톤 500T\n천안캠퍼스\n\xa0 \xa0 \xa0 555\n\xa0 \xa0 41,949,576\n\xa0 \xa0 \xa0 568\n\xa0 \xa0 43,162,884\n\xa0405\n\xa030,810,630\n스티렌 \xa0500T\n〃\n\xa0 \xa0 \xa0 321\n\xa0 \xa0 \xa0 8,588,360\n\xa0 \xa0 \xa0 253\n\xa0 \xa0 21,066,437\n\xa0360\n\xa029,538,492\n플라비톨 300T\n〃\n\xa0 \xa0 \xa0 107\n\xa0 \xa0 36,781,034\n\xa0 \xa0 \xa0 \xa098\n\xa0 \xa0 33,786,405\n\xa0115\n\xa039,372,883\n가스터 300T\n〃\n\xa0 \xa0 \xa0 337\n\xa0 \xa0 19,889,035\n\xa0 \xa0 \xa0 353\n\xa0 \xa0 20,754,294\n\xa0374\n\xa021,660,815\n리피논 300T\n〃\n\xa0 \xa0 \xa0 106\n\xa0 \xa0 22,454,406\n\xa0 \xa0 \xa0 117\n\xa0 \xa0 24,188,502\n\xa0100\n\xa020,905,927\n오팔몬 84T\n〃\n\xa0 \xa01,343\n\xa0 \xa0 36,075,320\n\xa0 \xa0 \xa0 956\n\xa0 \xa0 25,684,539\n\xa01,192\n\xa032,043,756\n주블리아 4mL\n〃\n\xa0 \xa0 \xa0 784\n\xa0 \xa0 33,895,359\n\xa0 \xa0 \xa0 840\n\xa0 \xa0 33,688,569\n\xa0670\n\xa026,133,471\n크로세린30캡슐\n〃\n\xa0 \xa0 \xa0 782\n\xa0 \xa0 \xa0 9,073,956\n\xa0 \xa0 \xa0 885\n\xa0 \xa0 \xa0 9,995,784\n\xa01,220\n\xa012,916,678\n그로트로핀주\n대구캠퍼스\n\xa0 \xa0 \xa0 185\n\xa0 \xa0139,264,544\n\xa0 \xa0 \xa0 \xa095\n\xa0 \xa0 58,958,304\n\xa0197\n\xa053,141,550\n슈가논 30T\n송도캠퍼스\n\xa0 \xa01,991\n\xa0 \xa0 33,830,654\n\xa0 \xa02,366\n\xa0 \xa0 39,984,367\n\xa01,461\n\xa025,220,388\n기 타\n-\n\u3000-\n\xa0 \xa0241,834,248\n-\n\xa0 \xa0217,235,959\n\u3000-\n\xa0216,233,979\n합 계\n-\n\xa0 \xa0623,636,491\n\u3000-\n\xa0 \xa0528,506,043\n\u3000-\n\xa0507,978,568\n마. 가동률\n(단위 : 시간, %)\n사업소(사업부문)\n가동가능시간\n실제가동시간\n평균가동률\n모티리톤 500T\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,920\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 2,102\n109.5\n스티렌 \xa0500T\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,920\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,629\n84.8\n플라비톨 300T\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,920\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 2,265\n118.0\n가스터 300T\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,920\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,806\n94.0\n리피논 300T\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,920\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,953\n101.7\n오팔몬 84T\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,920\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 2,342\n122.0\n주블리아 4mL\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,920\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,911\n99.5\n크로세린30캡슐\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,920\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 2,038\n106.2\n그로트로핀주\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,920\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,204\n62.7\n슈가논정 30T\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,920\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,793\n93.4\n합 \xa0 \xa0 \xa0 계\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa019,200\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa019,043\n99.2\n바. 생산설비 현황(1) 개요 \xa0- 당사는 국내에 총 3개의 생산공장을 가동중에 있습니다. 주 공장인 천안캠퍼스는 \xa0캡슐제, 정제, 주사제를 생산하고 있으며, 대구캠퍼스는 바이오의약품을 생산하고 있으며 송도캠퍼스도 2023년부터 생산을 시작하였습니다.(2) 주요 생산설비 현황\r\n[자산항목 : 토지] \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0(단위 : 백만원)\n사업소\n소유형태\n소재지\n구분(㎡)\n기초장부가액\n당기증감\n당기상각\n기말장부가액\n비고(공시지가)\n증가\n감소\n송도캠퍼스\n자가보유\n인천시\n111,507\xa0\n57,978\xa0\n0\xa0\n0\xa0\n0\xa0\n57,978\xa0\n143,733\xa0\n천안캠퍼스\n자가보유\n천안시\n55,087\xa0\n23,860\xa0\n0\xa0\n0\xa0\n0\xa0\n23,860\xa0\n19,793\xa0\n대구캠퍼스\n자가보유\n달성군\n36,323\xa0\n6,027\xa0\n0\xa0\n0\xa0\n0\xa0\n6,027\xa0\n9,992\xa0\n합 계\n-\n-\n-\n87,865\xa0\n0\xa0\n0\xa0\n0\xa0\n87,865\xa0\n173,518\xa0\n[자산항목 : 건물] \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 (단위 : 백만원)\n사업소\n소유형태\n소재지\n구분\n기초장부가액\n당기증감\n당기상각\n기말장부가액\n비고(과세시가표준)\n증가\n감소\n송도캠퍼스\n자가보유\n인천시\n-\u3000\n0\xa0\n60,093\xa0\n0\xa0\n1,145\xa0\n58,949\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 7,190\xa0\n천안캠퍼스\n자가보유\n천안시\n-\u3000\n32,127\xa0\n0\xa0\n0\xa0\n1,508\xa0\n30,619\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 4,585\xa0\n대구캠퍼스\n자가보유\n달성군\n-\u3000\n8,991\xa0\n69\xa0\n0\xa0\n358\xa0\n8,702\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1,139\xa0\n합 계\n-\n-\n-\n41,118\xa0\n60,162\xa0\n0\xa0\n3,010\xa0\n98,270\xa0\n12,914\xa0\n[자산항목 : 구축물] \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0(단위 : 백만원)\n사업소\n소유형태\n소재지\n구분\n기초장부가액\n당기증감\n당기상각\n기말장부가액\n비고\n증가\n감소\n송도캠퍼스\n자가보유\n인천시\n-\u3000\n0\xa0\n0\xa0\n0\xa0\n0\xa0\n0\xa0\n-\n천안캠퍼스\n자가보유\n천안시\n-\u3000\n752\xa0\n0\xa0\n0\xa0\n45\xa0\n707\xa0\n-\n대구캠퍼스\n자가보유\n달성군\n-\u3000\n153\xa0\n0\xa0\n0\xa0\n9\xa0\n144\xa0\n-\n합 계\n-\n-\n-\n905\xa0\n0\xa0\n0\xa0\n54\xa0\n851\xa0\n-\n[자산항목 : 기계장치] \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 (단위 : 백만원)\n사업소\n소유형태\n소재지\n구분\n기초장부가액\n당기증감\n당기상각\n기말장부가액\n비고\n증가\n감소\n송도캠퍼스\n자가보유\n인천시\n-\u3000\n0\n33,909\n1\n2,294\n31,615\n-\n천안캠퍼스\n자가보유\n천안시\n-\u3000\n11,607\n1,274\n501\n3,716\n8,664\n-\n달성캠퍼스\n자가보유\n달성군\n-\u3000\n3,432\n1,766\n0\n1,723\n3,475\n-\n합 계\n-\n-\n-\n15,039\n36,949\n502\n7,732\n43,753\n-\n사. 설비의 신설, 매입 계획 등 - 해당사항 없음\n']"
